In Pennsylvania’s first precedent-setting case on hormone replacement therapy mass tort litigation, a Philadelphia judge told the Superior Court the case should be retried because a jury concluded one drugmaker was liable for the plaintiff’s breast cancer and concluded another drugmaker was not liable even though the plaintiff was taking the hormonal drugs at the same time.
The Superior Court retained jurisdiction over Simon v. Wyeth after reversing Philadelphia Common Pleas Judge Nitza I. Quinones Alejandro’s decision to grant judgment notwithstanding the verdict in the case Dec. 31. The appellate court ordered Quinones to write a supplemental opinion addressing defendant Pharmacia & Upjohn’s motion for a new trial.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
